Astrazeneca vaccine trial in UK stopped after volunteer fell ill (Representative) New Delhi: The Serum Institute of India (SII) is set to restart coronavirus vaccine trials, pending permission from the General Medicines Controller of India (DGCI), the manufacturer said in a statement Saturday night. IBS had suspended recruitment for the …
Read More »Serum Institute to Resume Trial in India After DCGI Approval
After Astrazeneca resumed testing of the Oxford University coronavirus vaccine in the UK, the Serum Institute of India said on Saturday it will restart the trial in the country once allowed by the main drug regulator. Commenting on the resumption of the trial, Adar Poonawalla, executive director of the Serum …
Read More »Astrazeneca gets regulator go-ahead to resume Oxford vaccine trial in UK
British-Swedish firm Astrazeneca said it had resumed testing of the coronavirus vaccine from the University of Oxford in the UK following confirmation from the Medicines Health Regulatory Authority (MHRA). The advanced COVID-19 vaccine trial developed by the University of Oxford and Astrazeneca was suspended this week after illness in a …
Read More »Suspend new recruitment for the Covid vaccine
Corononavirus: More than 45 lakh people in India have been affected by the pandemic so far. New Delhi: The new recruitment for the University of Oxford’s Phase 2 and Phase 3 trials of the Covishield vaccine being manufactured in India by the Serum Institute of India, along with leading drugmaker …
Read More »Serum Stops Oxford Vaccine Trials Following DCGI Notice | India News
Representative image NEW DELHI/ MUMBAI: Serum Institute of India stopped the Covishield trials, Oxford University-AstraZenecaCandidate for the Covid-19 vaccine, after a notice issued by the central drug regulator. “We are reviewing the situation and stopping the trials in India until AstraZeneca restarts them. We are following the instructions of the …
Read More »Serum Institute Stops Covid-19 Vaccine Trials In India Even As AstraZeneca Says End-of-Year Launch Still Possible
In this illustration, taken on April 10, 2020, small vials labeled with a “COVID-19 Vaccine” label and a medical syringe are seen (REUTERS / Dado Ruvic / Illustration / File photo). The Serum Institute of India halted trials of the Covid-19 vaccine in India one day after AstraZeneca halted trials …
Read More »UN Calls For ‘Quantum Leap’ In Covid-19 Vaccine Funding, Says $ 15 Billion Will Be Needed In Next 3 Months
A staff member places a Sinovac Biotech Ltd coronavirus vaccine candidate on its booth for display during the 2020 China International Trade in Services Fair (CIFTIS), following the COVID-19 outbreak, in Beijing, China, on September 5, 2020. REUTERS / Tingshu Wang UN Secretary General Antonio Guterres urged countries to find …
Read More »Serum Institute Halts Covishield Vaccine Trials in India
A day after the Serum Institute of India (SII) received a demonstration cause notice from the Controller General of Drugs of India (DCGI), it said it was pausing trials of the Covid-19 vaccine in the country. IBS is manufacturing the Covishield vaccine at the University of Oxford in collaboration with …
Read More »Serum Institute suspends trial in India
The Serum Institute of India said on Thursday it was halting the University of Oxford-Astrazeneca’s COVID-19 vaccine trial in India until the British-Swedish drugmaker restarts the trial. The move came a day after the Pune-based vaccine maker received a notice of demonstration cause from the Drugs General Inspector of India …
Read More »Serum Institute to Suspend Vaccine Trials in India Following Drug Controller Notice
The Serum Institute of India said it will halt the Phrase 3 trials that were due to start in India next week. New Delhi: The Serum Institute of India, which is manufacturing the Covishield coronavirus vaccine being developed by the University of Oxford in conjunction with major pharmaceutical company AstraZenca, …
Read More »